CA1287881C - Power supply for body implant - Google Patents

Power supply for body implant

Info

Publication number
CA1287881C
CA1287881C CA000513840A CA513840A CA1287881C CA 1287881 C CA1287881 C CA 1287881C CA 000513840 A CA000513840 A CA 000513840A CA 513840 A CA513840 A CA 513840A CA 1287881 C CA1287881 C CA 1287881C
Authority
CA
Canada
Prior art keywords
winding means
primary winding
power factor
implanted
voltage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA000513840A
Other languages
French (fr)
Inventor
David Henry Laforge
James Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Edwards Lifesciences Corp
Original Assignee
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter International Inc filed Critical Baxter International Inc
Application granted granted Critical
Publication of CA1287881C publication Critical patent/CA1287881C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/50Details relating to control
    • A61M60/585User interfaces
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/10Location thereof with respect to the patient's body
    • A61M60/122Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body
    • A61M60/165Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable in, on, or around the heart
    • A61M60/178Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable in, on, or around the heart drawing blood from a ventricle and returning the blood to the arterial system via a cannula external to the ventricle, e.g. left or right ventricular assist devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/80Constructional details other than related to driving
    • A61M60/855Constructional details other than related to driving of implantable pumps or pumping devices
    • A61M60/871Energy supply devices; Converters therefor
    • A61M60/873Energy supply devices; Converters therefor specially adapted for wireless or transcutaneous energy transfer [TET], e.g. inductive charging
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/82Internal energy supply devices
    • A61M2205/8237Charging means
    • A61M2205/8243Charging means by induction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/10Location thereof with respect to the patient's body
    • A61M60/122Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body
    • A61M60/126Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel
    • A61M60/148Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel in line with a blood vessel using resection or like techniques, e.g. permanent endovascular heart assist devices

Abstract

POWER SUPPLY FOR BODY IMPLANT
ABSTRACT

An implanted blood pump system is described wherein power for driving the pump is provided by a transcutaneous transformer having an external primary winding and an implanted secondary winding. Control of the driving voltage to the pump is provided by an implanted shunt regulator. Voltage applied to the primary winding is controlled in accordance with the power factor sensed in the primary winding.

Description

~Q~R_&~Ph~_~QB_~QDY IM~hA~T
This invention relates to electric power supplies, and more particularly to a power supply ~or an electrical circulatory support device which is implanted within a living body.
The relatively hiyh amount of power required by circulatory s~pport devices (blood pumps), such as a : pa~tial or total artificial heart, has rendered most implantablet self-sufficient energy sources 1~ inapplicable, such as those used for a pacemaker. Only high-power, radioisotope heat sources have held any promise of sustained outputs of several watts, however, the utilization of such an energy source has been complicated by its inherent need for a miniature, high - 1~ efficiency heat engine, as wel~ as by serious .~ radiation-related problems. All other practical approaches to powering an artificial heart or circulatory assist system of some type necessarily depend on a more or less continuous flow of energy from outside the body. Results of efforts at infection-free ~ maintenance o~ long-term percutaneous connections are :~ discouraging and thus highlight the desirability, at : least for the long term, of powering such an implanted device though intact skin~
2~ One of the earlie~t approaches to the transmission of energy across intact skin involves the generation of a radio frequency field extending over a substantial area of the body, such that significant - power could be extracted from coils located in the vicinity of the implanted power-consuming device - itself. Placement of substantial amounts of ferrite materials within such coils to permit the capture of a greater proportion of the incident field was also investigated, a~ reported in the article by J.C.
~5 Schuder, et al. in the 1964 Transactions ACE~B.
However, difficulty has been experienced in reconciling .~.

,, . ~ :; .. ' : .
- , , .: .

. .
. , .
' .

~.~ 8 ~

the conflicting requirement of magnetic circuit geometry with a surgically feasible, variable tissue structure. In another proposed alternative design, a ~econdary coil is implanted in such a manner that the center of the coil remains accessible through a surgically constructed tunnel of skin; however, such devices have not yielded satisfactory performance.
Predominant failure modes include necrosis of the skin tunnel tissue caused by mechanical pressure and excess heat generation - see the 1975 report of I . I ,T.
Research Institute, by BruesGhke, et al., N.I~H. Report No. N01-HT-9-21~5-3, page 25.
In ~.S. Patent No. 4,143,661, issued ~arch 13, 1979, assigned to the assignee of the present invention, a so-called belt skin transformer ~BST~
system is described in which a secondary coil is implanted just below the skin of the abdomen or the thigh so that it encircles the patient's torso or leg along most of the length of the coil and lies at a location close to the skin's surface. A primary coil, in the form of an encircling belt which is greater in width than the secondary implanted coll, fits around the patient in the region just radially outward of the secondary coil. Power is supplied to the primary coil, which is then inductively coupled transcutaneously to the secondary coil, which in turn operates the device and charges and implanted storage battery~
Naturally, proper circuit design in a BST
system requires regulation of the voltage applied to the load or blood pump. Although a variety of regulatory expedients are known in the prior art, the uniqueness of the transcutaneous transformer arrangement employed in systems of this type makes the prior art of little value in predicting ideal arrangements~ X~ has been found that a ~wo tier regulation ~cheme, employing an internal regulator for , ..

, ~ .

~7~

driving the blood pump itself, and employing an external regulator for controlling voltage input to the primary winding, is particularly desirable.
Coordination of the two regulators may, of co~rse, be achieved by suitable telemetry signals. ~owever, such telemetry circuitry adds additional expense, complexity, and unreliability factors to the system.
It is an object of the present invention to provide an improved implanted blood pump system and method for operating same~
Another object of the invention is to provide an implanted blood pump system in which a highly effective means of voltage regulation is achieYed.
Another object of the invention is to provide 1~ an improved implanted blood pump system which coordinates regulation of the voltage applied to the system in accordance with load demands and without the need for telemetry monitoring.
Other objects of the invention will become apparent to those skilled in the art from the following description, taken in connection with the accompanying drawings ~herein:
- FIGURE 1 is a diagrammatic depiction of the implanted portion of a power supply system shown in ~S conjunction with a circulatory blood pump within a living human;
FIGURE 2 is a block diagram of the system illustrated in FIGURE l;
FIGURE 3 is a schematic diagram illustrating the secondary transformer of ~he system of FIGU~E 1 connected to rectifi~r, voltage regulator/ and other implanted elements including the blood pump itself (implanted load~; and FIGURE 4 is a schematic diagram of the primary winding power circuit utilized in the sy~tem of FIGURE
1 .

' .' :, , ' . ' ' ' ~ ' , ' : :, ..... ' - ' ' 9 ~78B~

~4--Very yenerally, in the implanted blood pump sy~tem of the invention, power for driving the pump is provided by a transcutaneous transformer having an external primary winding and an implanted secondary winding and an implanted shunt regulator. Ths secondary winding applies driving voltage to the pump which is controlled by the shunt regulator. The voltage applied to the system is regulated by sensing the power factor in the primary and comparing the power factor to a predetermined power factor level selected to correspond with a desired driving voltage~ The voltage level in the primary winding is adjusted to substantially equalize the sensed power factor and the predetermined power factor level.
Referring now more particularly to FIGURE 1, a blood pump in the form of a left ventricular assist device 11 is depicted implanted within the body 13 of a patient. The device is preferably of the type shown and described in U.S. Patents Nos. 4,4577673 and 4,384,829. The system also includes an implanted ; module 15 that includes electronic rectifying and control components and a standby storage battery.
The system is powered and charged via coupling to a primary coil which is constituted by an outer belt 17 having a disconnec~able belt buckle 19. A secondary coil, not visible in FIGURE 1, but designated as 21 in FIGURES 2 and 3 is implanted in the abdomen about the waist~ The primary coil 17 overlaps the secondary coil 21 and, when positioned about the waist o a wearer, is inductively coupled to the secondary coil 21. Because of the relatively large diameter of the two air core coils, a very high mayne~ic coupling coefficient is achieved in an overall light weight iron free sys~em.
Referring now to FIGURE 2, the belt skin transformer (BST) comprising the primary winding 17 and the secondary winding 21 is driven by a BST driver, 23 ,' ' ' ~ ' , ' ~ .

~'' , . .' .,~ , ' ' ' ''' ' . ' ' 7~38~

more fully explained below. Power for the BST driver may be supplied fro~ any suitable source, such as a normal alternating current line, a vest battery, a car battery, etc. and is indicated generally by the element s 25 in FIGURE 2 As may be seen in ~'IGURE 2 and as is more specifically illustrated in FIGURE 3, the secondary windiny which has a plurality of parallel wires wound in a single turn with respect to the primary~ is coupled to a tertiary winding 27. It i5 preferable for all secondary windings to be parallel because: l) it is more reliable because of its redundancy; 2) the greatest potential between windings and tissue is less than one volt; 3) a simple single circuit connector can be used; 4) there is no danger of short circuits between windings of different potential.
It is preferable to space the wires for flexibility and because they thus form a wide "current sheet" which reduces formation of parasitic leakage fields (as around a small wire~ which would fail to couple with the primary belt.
Both windings 21 and 27 are wound on a common toroidal core 29. This particular design is useful in functioning as a current equalizing device. The separate equivalent transformers of the wixes of the ~ingle-turn coil 21 and the multi-turn coil 27 are interleaved in windings equally spaced around the core 29. Since these transformers are physically parts of the same core, they exhibit a very high coupling~ In fact, their individual coupling is typically about 98%.
Intercoupling between the windings, however, is typically only about 85%. Hence, there is a tendency toward a current equalization and thus a cancelling of local fields within the belt. This eliminates conductor degradation and electrical losses which might be encountered in the event of unbalanced surrents in the parallel wires of the single-turn coil 21.

, , ,: ' .

~ ~7~

Output from the winding 27l which will be more specifically described belowr is applied to a voltage regulator and battery switching circuit 31 which, in turn, drives the implanted device ll. A standby battery 33 is also used for periods in which the external power supply in the form of the BST driver 23 is temporarily disconnected. Suitable implanted telemetry circuitry 35 and external telemetry circuitry 37 are co~pled by telemetry pick-off units 3~ and 41, respectively, in order to permit monitoring and control of the implanted device by means of the monitor/control unit 39.
The implanted load or heart assist device ll is driven from the tertiary winding 27 by a pair of Schottky diodes 41 and 43, which are connected as full-wave rectifiers to the implanted load ll. The Schottky diodes are used to minimi~e voltage drop and may be of the type lN5825. The output voltage of the rectifier is smoothed by a capacitor 45 connected across the load. An auxiliary battery 47 is provided connected through a diode 49 across the load to supply auxiliary or standby power to the load. A switch and current regulating charge control 51 is provided for the battery 47 and may be of any suitable design to charge the battery from the positive portion of the rectified signal. Suitable signals may be developed from the implanted device to switch the charge control on and off. If the positive power to the implanted load drops below that of the battery 47 r the diode 49 conducts, providing the standby power to the load.
In order to internally regulate the power - provided to the implanted load, a shunt regulator is provided. The shunt regulator includes a reference voltage source 55 connected through a low voltage, low frequency sscillator 57 (sometimes known as a "dithern3 to a voltage comparator amplifier 59. The '' ': ' . - ':' . ~

~, ~ 2 ~7 ~

voltage output of the voltage comparator 59 is connected to the gates of a pair of SCR switches 61 and 63. ~he switches are connected across respective portions of the tertiary winding 27 and operate to shunt the output thereof, when the switches are closed, from the rectifying diodes 41 and 43, thus blocking the flow of power to the smoothing capacitor 45. During such periods the implanted load is supplied with power by discharge of the smoothing capacitor.
In operation, the shunt regulator is configured such that the switches 61 and 63 remain open whèn the voltage output of the rectifiers 41 and 43 is high enough to drive the load 11 and charge the battery 47~ when applicable. This voltage, which is near the 15 ref erence level 55, is sensed by the voltage comparator 59. When the voltage output of the diodes 41 and 43 exceeds the reference level, the voltage comparator 59 provides an output to the gates of the switches 61 and 63, turning the switches on (i.e. closing the switches). Under such circumstances, the tertiary winding 27 and hence the secondary winding 21 i5 effectively shorted. The frequency at which ~he switches 61 and 63 are operated is selected to be much lower than the power frequency in the tertiary winding 27 to minimi~e switching losses t simplify control and reduce undesirable harmonic generation. The oscillator 28 assists in ~he maintenance of the low frequency switching by causing the shunt regulator switching to occur at a predetermined fixed frequency, for example about 1 kHz, which simplifies the primary circuit regulator. As an alternative, the comparator 59 may be provided with a switching histeresis or dead band in accordance with known practice~
Referring now to FIGURE 4, the components of the BST driver 23 are illustrated. ~he primary winding 17 is connected via a capacitor 65 and series resis~or . ' ~ : ' ' ' ' :
.

..

~ ~8~

67 to ground. A pair of power switches couple a source of positive voltage ~for example a 12 volt automotive battery), or to ground. The power switches 69 and 71 are series connected with their junction being connected to one end of the primary winding 17. The primary winding 17 and the series capacitor 65 and resistor 67 form a series resonant circuit and the frequency at which the primary winding 17 is driven is determined by this resonance. Typically, this frequency will be approximately 80 kHz and will change in response to respiration and other mechanical factors effecting the inductance of the primary winding 17.
Phase lock of the driver circuit to the primary resonance is accomplished by switching the power circuit via the power switches 69 and 71 to the positive power source when zero current is detected.
This also facilitates self starting of the systemO
In order to drive the switches 69 and 71 at the desire~ frequerlcy, a driver circuit 73 is provided.
~ This driver circuit, which may be any suitable amplifier driver, is coupled to the gates of the switches 69 and 71 and is controlled such that the duration of the on time of the power switches 69 and 71 determines the duty cycle and therefore the total power which is applied to the primary winding 17.
In order to detect the current in the primary winding 17, the resistor 67 is connected to an amplifier 75 which develops a signal proportional to the current in the primary winding 17. This signal is applied ~hrough a comparator 77 and through a gate 79 o a flip-flop 81. The comparator 77 is a digital output comparator which develops a digital signal which is a square wave at a frequency which is in phase with the current in the primary winding 17. This digital ~5 signal sets the flip-~lop 81 through the gate 79, initiating a drive pulse from ~he flip-flop ~1 to the .
' , ', ' ' , " . ', ' , driver 73. The driver circuit 73 operates to amplify this pulse to control the switches 69 and 71 and to ensure that both switches cannot conduct simultaneously.
In order to control the width of the pulse output in the primary winding 17, the relative width of the pulse applied from the flip-flop 81 to the driver 73 is controlled. Since the power frequency may change, it is preferable to generate a pulse having a certain fraction of the period T = l/F, rather than a pulse of a fixed duration. In order to do this, a reference frequency is generatedl for example a reference of 32 x F. To this end, a preset counter 83 is provided connected to the gate 79 and the flip-flop 81. The counter, which may for example be industry type 4510, begins to count at the reference frequency (in the example 32F) when the gate 85, connected to the input of the preset counter 83, is enabled. When the preset count is reached, the flip-flop 81 is reset, ending the pulse to the driver 73 and thus turning off the power switches 69 and 71. The gate 79 operates to prevent the flip-flop 81 from turning on again, even if the signal output of the comparator 77 is still high.
When the signal output of the comparator 77 is low, an inverter 87, connected to the preset counter 83, resets the preset coun~er 83 to the preset number.
This preset number may be derived from an up-down counter 89, connected to the preset counter 83 and which may also be of the industry type 4510. On the basis of a reference frequency of 32 times the resonant frequency, the counter 83 may be set for a maximum count of 15. Thus, the 16th pulse will terminate the output of the driver 73. In this example, since the co~nter 83 is counting at a frequency of 32 times the resonant frequency, the greatest possible width Gf the output pulse is 50% o~ the period T = l/F, : ' ' , ' ~ ' .
.

corresponding to a full power square wave drive. Lower preset counts, of course, give narrower pulses of lower power level.
In order to derive the reference frequency from the signal output of the csmparator 77, a conventional phase lock loop 91 is utilized. Phase lock loops are generally well known in the art and may employ a simple binary counter and loop filter combined with other appropriate elements in a single chip, such as ind~stry type 215 or 565.
Voltage in the primary winding 17 is sensed by a differential amplifier 93. ~he amplifier 93 generates an analog of the voltage in the primary winding 17 which is then applied to a multiplier 95 ~for example, type 1496). The output from the amplifier 75 is also applied to the multiplier 32. The multiplier acts as a phase sensitive detector and its output has a substantial average value (DC component) if and only if the impedanc~ of the primary winding 17 has a substantial resistive component. The output of the multiplier 95 is fed through a low-pass filter 97 ~which removes product components of the resonant frequency of the primary winding 17 and higher frequencies) to a comparator 99. The comparator 99 is connected to an adjustable offset pot lOl which permits the threshold of the comparator 99 to be set sufficiently high as to reject output from the filter 97 resulting from noise and power dissipated ln the resistance of the belt skin transformer.
The output of the comparator is applied to two monostable multivibrators l~ and 105. Each of the monostable multivibra~ors 103 and lOS produces pulses of adjustable length "L" and "H", re~pectively. Æach multivibrator is connected to a variable resistor J 107 and lO9, respectively, which cons~itute part of the timing circuits of the multivibrators. For exampler , , ' . , ' ~ ' ~ ., . . . "
: , ~ ~37~

the multivibrators could be the two halves of a type 4528 chip. The dif~erence in settings between L and H
serves as a refractory or dead zone to help reject noise and prevent the implanted and primary regulators from interacting. The multivibrators control a pair of gates 111 and 113, respectively, which are connected to the up-down counter 89 and serve, as will be explained, to adjust the up-down counter 89 and therefore the preset counter 83 to control the width of the pulses in the primary winding 17.
Referring now more particularly to the operation of the device, as previously mentioned, when the shunt regulator in the implanted circuitry is open, the lsad which ~he primary winding 17 sees is primarily resistive. However, once the shunt regulator switches close, the load becomes primarily inductive. During the time that this shunt regulator is conducting current, current is circulating unproductively in the coils of the belt skin transformer, thus contributing to resistive losses. It is ~herefore desirable to adjust the power level in the primary winding as low as possible consistent with maintaining secondary shunt regulator control. In accordance with the invention, the conduction angle or power factor in the primary - ~5 winding 17 is sensed and the duty cycle of the primary drive pulse is controlled accordingly. Power factor is defined as cos p where ~ is the phase angle between current and voltage. A power factor of unity indicates the load is purely resistive.
More particularly, the multiplier 95 operates to compare and thus detect the phase relation between voltage and current in the primary winding 17. As such, the output signal of the multiplier 95 is high when the switches 61 and 63 are open reflecting a resistive load, and is low when the ~witches 61 and 63 are closed, reflecting an inductive load~ The output ~37 of the multiplier 95 is therefore a series of pulses of a frequency F fixed by the oscillator 57 and having a duty factor equal to the load conduction factor on the shunt regulator 61, 63O
Each positive ongoing edge of the p~lses represented by the output of the multiplier 95 triggers the monostable multivibrators 107 and 109. The output is a pair of pulses of length L and ~, respectively, the length of which is set by adjustment of the variable resistors 107 and 109. For example, if the frequency of the output of the multiplier 95 is 1 k~z, corresponding to a pulse period in the primary winding 17 of 1 millisecond, H might be set to 0.9 milliseconds and L might be set to 0~6 milliseconds. The difference between L and H, namely, 0.3 milliseconds, serves as the refractory or dead zone which minimizes interaction between the implanted and external regulators.
If the duration of each pulse in the output of the multiplier 95 is less than H but greater than L, the implanted shunt regulator is considered within its ideal operating range (60~ to 90% load conduction)l Neither of the gates 111 or 113 produce outputs. The number in the up~down counter 89 is unchanged and therefore the duty cycle of the pulse in the primary winding 17 is constant. If puls2 ~ ends before the end of the pulse from the multiplier 95, the gate 111 will produce an output which adds one count to the up-down counter 89 for each occurrence. Upon such occurrence, the width of the pulses in the primary winding 17 is increased, delivering more power to the implanted circuitry. On the other hand, if the pulse from the multiplier 95 ends before ~he pulse L~ the gate 113 will produ~e an ou~put which decreases the count in ~he ~ up~down counter 89 and thus reduces the width of the : 3S pulses applied to the primary winding 17. By such means, the power level reaching the secondary of the , .,, . ~ ;
: , ~ . ' - . ,' ' ~ ." . '' ' ~, '.. ' '' - '. ' ' : ' . . '~ ' ,. ' ' , ' ' . ' '' , ' '. : , . - , . . .
.
: , , ' " ' ' . ,' : . i ,, ' ~ ~7~

belt skin transformer is controlled so that the implanted regulator components can efficiently stabilize the belt skin transormer outp~t voltage.
It may be seen, therefore, that the system and method of the invention operate to effectively regulate the power levels applied to the implanted blood pump sys~em described. A two tier regulation scheme is employed wherein a shunt regulator in the implanted circuit controls the load vol~age and wherein a primary regulator senses the conduction angle of the shunt regulator and adjusts the primary power level, by changing the duty factor of the primary drive pulse.
Accordingly, unproductive circulation of current in the transcutaneous transformer and consequent resistive lS losses are minimized. As a consequence, close regulation of the power to the implanted device is achieved without the necessity of elaborate telemetry control.
Various modifications of the invention in addition to those shown and described herein will become apparent to those skilled in the art from the - foregoing descrip~ion and accompanying drawings~ 5uch modific~tions are intended to fall wit~in the scope of the appended claims.

: . . . ,: : . .
., . . , : :
.. . -. -.
'. , ' : ' ';; ,' ~
,....... - . ~

Claims (10)

The embodiments of the invention in which an exclusive property or privilege is claimed are defined as follows:
1. In an implanted blood pump system wherein power for driving the pump is provided by a transcutaneous transformer having an external primary winding means and an implanted secondary winding means and shunt regulator means for controlling the driving voltage applied to the pump, a method for regulating the driving voltage applied to the primary winding means, comprising, sensing the power factor in the primary winding means, comparing the sensed power factor to a predetermined power factor level selected to correspond with a desired pump driving voltage, and adjusting the voltage level in the primary winding means to substantially equalize the sensed power factor and the predetermined power factor level.
2. A method according to Claim 1 wherein the power factor in the primary winding means is sensed by comparing the voltage and the current signals in the primary winding means and producing a control signal which is responsive to operation of the shunt regulator means.
3. A method according to Claim 1 wherein the voltage level in the primary winding means is adjusted by varying the width of pulses applied thereto.
4. An implantable blood pump system comprising, an implanted pump and a transcutaneous transformer having an external primary winding means and an implanted secondary winding means, said system further comprising implanted shunt regulator means for controlling the driving voltage applied to said pump, means for sensing the power factor in said primary winding means, means for comparing the sensed power factor to a predetermined power factor level selected to correspond with a desired driving voltage for said pump, and means for adjusting the voltage level in said primary winding means to substantially equalize the sensed power factor and the predetermined power factor level.
5. Apparatus according to Claim 4 wherein said power factor sensing means includes means for comparing the voltage and the current signals in said primary winding means and for producing a control signal which is responsive to operation of said shunt regulator means.
6. Apparatus according to Claim 4 including means for varying the width of pulses applied to said primary winding means to control the voltage level therein.
7. Apparatus according to Claim 4 wherein said shunt regulator means include switching means connected across said secondary winding means, and voltage comparator means for turning on said switching means when the voltage across said secondary winding means exceeds a predetermined level.
8. A system according to Claim 4 including an implanted battery connected to said pump and further including means for connecting said battery to said pump when the voltage across said secondary winding means falls below a preselected level.
9. Apparatus according to Claim 4 wherein said secondary winding means include first and second inductively coupled winding means, each of said first and second inductively coupled winding means being wound on a common toroidal core.
10. Apparatus according to Claim 9 wherein the said first winding means comprise a plurality of parallel first windings in which the currents are made equal in addition to being coupled to the second winding means, by being disposed about said toroidal core with equal spacing.
CA000513840A 1985-07-22 1986-07-15 Power supply for body implant Expired - Lifetime CA1287881C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/757,786 US4665896A (en) 1985-07-22 1985-07-22 Power supply for body implant and method of use
US757,786 1985-07-22

Publications (1)

Publication Number Publication Date
CA1287881C true CA1287881C (en) 1991-08-20

Family

ID=25049214

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000513840A Expired - Lifetime CA1287881C (en) 1985-07-22 1986-07-15 Power supply for body implant

Country Status (10)

Country Link
US (1) US4665896A (en)
EP (1) EP0231346B1 (en)
JP (1) JPH0761360B2 (en)
AT (1) ATE80024T1 (en)
AU (1) AU6191486A (en)
BR (1) BR8606805A (en)
CA (1) CA1287881C (en)
DE (1) DE3686648T2 (en)
DK (1) DK145887D0 (en)
WO (1) WO1987000420A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9192704B2 (en) 2008-09-10 2015-11-24 Heartware, Inc. TET system for implanted medical device

Families Citing this family (174)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4781716A (en) * 1987-02-13 1988-11-01 Marc Richelsoph Artificial heart
US5024224A (en) * 1988-09-01 1991-06-18 Storz Instrument Company Method of readout of implanted hearing aid device and apparatus therefor
US5085628A (en) * 1988-09-09 1992-02-04 Storz Instrument Company Implantable hearing aid coupler device
US4988333A (en) * 1988-09-09 1991-01-29 Storz Instrument Company Implantable middle ear hearing aid system and acoustic coupler therefor
US4968293A (en) * 1989-03-20 1990-11-06 Medtronic, Inc. Circulatory assist device
US5350413B1 (en) * 1990-06-21 1999-09-07 Heart Inst Research Corp Transcutaneous energy transfer device
DE4104359A1 (en) * 1991-02-13 1992-08-20 Implex Gmbh CHARGING SYSTEM FOR IMPLANTABLE HOERHILFEN AND TINNITUS MASKERS
US5344385A (en) * 1991-09-30 1994-09-06 Thoratec Laboratories Corporation Step-down skeletal muscle energy conversion system
US5193539A (en) * 1991-12-18 1993-03-16 Alfred E. Mann Foundation For Scientific Research Implantable microstimulator
US5193540A (en) * 1991-12-18 1993-03-16 Alfred E. Mann Foundation For Scientific Research Structure and method of manufacture of an implantable microstimulator
US5565005A (en) * 1992-02-20 1996-10-15 Amei Technologies Inc. Implantable growth tissue stimulator and method operation
EP0561068B1 (en) * 1992-02-20 1999-03-03 Neomedics, Inc. Implantable bone growth stimulator
US5411537A (en) * 1993-10-29 1995-05-02 Intermedics, Inc. Rechargeable biomedical battery powered devices with recharging and control system therefor
US5947892A (en) * 1993-11-10 1999-09-07 Micromed Technology, Inc. Rotary blood pump
US5524624A (en) * 1994-05-05 1996-06-11 Amei Technologies Inc. Apparatus and method for stimulating tissue growth with ultrasound
US5630836A (en) * 1995-01-19 1997-05-20 Vascor, Inc. Transcutaneous energy and information transmission apparatus
US5702431A (en) * 1995-06-07 1997-12-30 Sulzer Intermedics Inc. Enhanced transcutaneous recharging system for battery powered implantable medical device
US5690693A (en) * 1995-06-07 1997-11-25 Sulzer Intermedics Inc. Transcutaneous energy transmission circuit for implantable medical device
US5810015A (en) * 1995-09-01 1998-09-22 Strato/Infusaid, Inc. Power supply for implantable device
US5728154A (en) * 1996-02-29 1998-03-17 Minnesota Mining And Manfacturing Company Communication method for implantable medical device
AUPO214396A0 (en) * 1996-09-04 1996-09-26 Cochlear Pty. Limited Compact inductive arrangement
AU711002B2 (en) * 1996-09-04 1999-10-07 Cochlear Limited Compact inductive arrangement
US5713939A (en) * 1996-09-16 1998-02-03 Sulzer Intermedics Inc. Data communication system for control of transcutaneous energy transmission to an implantable medical device
US5749909A (en) * 1996-11-07 1998-05-12 Sulzer Intermedics Inc. Transcutaneous energy coupling using piezoelectric device
US5995874A (en) * 1998-02-09 1999-11-30 Dew Engineering And Development Limited Transcutaneous energy transfer device
US6331744B1 (en) 1998-02-10 2001-12-18 Light Sciences Corporation Contactless energy transfer apparatus
US6281611B1 (en) 1998-02-10 2001-08-28 Light Sciences Corporation Use of moving element to produce heat
US5945762A (en) * 1998-02-10 1999-08-31 Light Sciences Limited Partnership Movable magnet transmitter for inducing electrical current in an implanted coil
US6058330A (en) * 1998-03-06 2000-05-02 Dew Engineering And Development Limited Transcutaneous energy transfer device
US7713297B2 (en) 1998-04-11 2010-05-11 Boston Scientific Scimed, Inc. Drug-releasing stent with ceramic-containing layer
US6324431B1 (en) 1998-07-06 2001-11-27 Abiomed, Inc. Transcutaneous energy transfer device with magnetic field protected components in secondary coil
US6324430B1 (en) 1998-07-06 2001-11-27 Abiomed, Inc. Magnetic shield for primary coil of transcutaneous energy transfer device
US8489200B2 (en) 1998-07-06 2013-07-16 Abiomed, Inc. Transcutaneous energy transfer module with integrated conversion circuitry
US6389318B1 (en) * 1998-07-06 2002-05-14 Abiomed, Inc. Magnetic shield for primary coil of transcutaneous energy transfer device
FR2784585B1 (en) * 1998-10-15 2001-01-26 Gie Carmat IMPLANTABLE HEART PROSTHESIS WITH INDEPENDENT VENTRICULAR CHAMBERS
WO2000024456A1 (en) 1998-10-27 2000-05-04 Phillips Richard P Transcutaneous energy transmission system with full wave class e rectifier
US6442434B1 (en) * 1999-10-19 2002-08-27 Abiomed, Inc. Methods and apparatus for providing a sufficiently stable power to a load in an energy transfer system
US6579315B1 (en) 2000-04-25 2003-06-17 The Penn State Research Foundation Artificial heart power supply system
US6478820B1 (en) 2000-04-25 2002-11-12 The Penn State Research Foundation Artificial heart with synchronous rectification
US6395027B1 (en) 2000-04-25 2002-05-28 The Penn State Research Foundation Artificial heart with arrhythmia signalling
US6458164B1 (en) 2000-04-25 2002-10-01 The Penn State Research Foundation Artificial heart with energy recovery
US6451055B1 (en) 2000-04-25 2002-09-17 The Penn State Research Foundation Artificial heart data communication system
US6327504B1 (en) 2000-05-10 2001-12-04 Thoratec Corporation Transcutaneous energy transfer with circuitry arranged to avoid overheating
US6808483B1 (en) 2000-10-03 2004-10-26 Paul A. Spence Implantable heart assist devices and methods
GB0106250D0 (en) * 2001-03-13 2001-05-02 Hall Effect Technologies Ltd Apparatus and method for analysing blood
US7727221B2 (en) 2001-06-27 2010-06-01 Cardiac Pacemakers Inc. Method and device for electrochemical formation of therapeutic species in vivo
US7151378B2 (en) * 2001-09-25 2006-12-19 Wilson Greatbatch Technologies, Inc. Implantable energy management system and method
US8147544B2 (en) * 2001-10-30 2012-04-03 Otokinetics Inc. Therapeutic appliance for cochlea
US6772011B2 (en) 2002-08-20 2004-08-03 Thoratec Corporation Transmission of information from an implanted medical device
US7003353B1 (en) 2002-12-10 2006-02-21 Quallion Llc Photovoltaic powered charging apparatus for implanted rechargeable batteries
DE10302550B3 (en) * 2003-01-22 2004-08-12 Forschungszentrum Karlsruhe Gmbh Belt reel as a transmit / receive antenna in a transponder device
AU2003904032A0 (en) * 2003-08-04 2003-08-14 Ventracor Limited Improved Transcutaneous Power and Data Transceiver System
JP4153852B2 (en) * 2003-09-18 2008-09-24 オリンパス株式会社 Energy supply coil and wireless in-vivo information acquisition system using the same
US20050075696A1 (en) 2003-10-02 2005-04-07 Medtronic, Inc. Inductively rechargeable external energy source, charger, system and method for a transcutaneous inductive charger for an implantable medical device
US8140168B2 (en) 2003-10-02 2012-03-20 Medtronic, Inc. External power source for an implantable medical device having an adjustable carrier frequency and system and method related therefore
US20060034943A1 (en) * 2003-10-31 2006-02-16 Technology Innovations Llc Process for treating a biological organism
US20050288740A1 (en) * 2004-06-24 2005-12-29 Ethicon Endo-Surgery, Inc. Low frequency transcutaneous telemetry to implanted medical device
US7599744B2 (en) * 2004-06-24 2009-10-06 Ethicon Endo-Surgery, Inc. Transcutaneous energy transfer primary coil with a high aspect ferrite core
US7599743B2 (en) * 2004-06-24 2009-10-06 Ethicon Endo-Surgery, Inc. Low frequency transcutaneous energy transfer to implanted medical device
US20050288739A1 (en) * 2004-06-24 2005-12-29 Ethicon, Inc. Medical implant having closed loop transcutaneous energy transfer (TET) power transfer regulation circuitry
US9192772B1 (en) 2004-06-29 2015-11-24 Quallion Llc Portable medical power system
US7828711B2 (en) * 2004-08-16 2010-11-09 Cardiac Pacemakers, Inc. Method and apparatus for modulating cellular growth and regeneration using ventricular assist device
US8073548B2 (en) * 2004-08-24 2011-12-06 Sensors For Medicine And Science, Inc. Wristband or other type of band having an adjustable antenna for use with a sensor reader
US20060089709A1 (en) * 2004-10-21 2006-04-27 Helmus Michael N Medical implant with average surface charge density
US7775966B2 (en) 2005-02-24 2010-08-17 Ethicon Endo-Surgery, Inc. Non-invasive pressure measurement in a fluid adjustable restrictive device
US7927270B2 (en) 2005-02-24 2011-04-19 Ethicon Endo-Surgery, Inc. External mechanical pressure sensor for gastric band pressure measurements
US8016744B2 (en) 2005-02-24 2011-09-13 Ethicon Endo-Surgery, Inc. External pressure-based gastric band adjustment system and method
US7699770B2 (en) 2005-02-24 2010-04-20 Ethicon Endo-Surgery, Inc. Device for non-invasive measurement of fluid pressure in an adjustable restriction device
US7775215B2 (en) 2005-02-24 2010-08-17 Ethicon Endo-Surgery, Inc. System and method for determining implanted device positioning and obtaining pressure data
US7658196B2 (en) 2005-02-24 2010-02-09 Ethicon Endo-Surgery, Inc. System and method for determining implanted device orientation
US8066629B2 (en) 2005-02-24 2011-11-29 Ethicon Endo-Surgery, Inc. Apparatus for adjustment and sensing of gastric band pressure
US7502594B2 (en) * 2005-04-27 2009-03-10 Codman Neuro Sciences Sárl Power regulation feedback to optimize robustness of wireless transmissions
US7774069B2 (en) * 2005-04-29 2010-08-10 Medtronic, Inc. Alignment indication for transcutaneous energy transfer
KR101136889B1 (en) 2005-07-12 2012-04-20 메사추세츠 인스티튜트 오브 테크놀로지 Wireless non-radiative energy transfer
US7825543B2 (en) * 2005-07-12 2010-11-02 Massachusetts Institute Of Technology Wireless energy transfer
US8840660B2 (en) 2006-01-05 2014-09-23 Boston Scientific Scimed, Inc. Bioerodible endoprostheses and methods of making the same
US8089029B2 (en) 2006-02-01 2012-01-03 Boston Scientific Scimed, Inc. Bioabsorbable metal medical device and method of manufacture
US20070224235A1 (en) 2006-03-24 2007-09-27 Barron Tenney Medical devices having nanoporous coatings for controlled therapeutic agent delivery
US8187620B2 (en) 2006-03-27 2012-05-29 Boston Scientific Scimed, Inc. Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents
US8152710B2 (en) 2006-04-06 2012-04-10 Ethicon Endo-Surgery, Inc. Physiological parameter analysis for an implantable restriction device and a data logger
US8870742B2 (en) 2006-04-06 2014-10-28 Ethicon Endo-Surgery, Inc. GUI for an implantable restriction device and a data logger
US8048150B2 (en) 2006-04-12 2011-11-01 Boston Scientific Scimed, Inc. Endoprosthesis having a fiber meshwork disposed thereon
US8815275B2 (en) 2006-06-28 2014-08-26 Boston Scientific Scimed, Inc. Coatings for medical devices comprising a therapeutic agent and a metallic material
JP2009542359A (en) 2006-06-29 2009-12-03 ボストン サイエンティフィック リミテッド Medical device with selective covering
US8521303B2 (en) * 2006-07-17 2013-08-27 University Of Utah Reasearch Foundation In vivo implantable coil assembly
US8052743B2 (en) 2006-08-02 2011-11-08 Boston Scientific Scimed, Inc. Endoprosthesis with three-dimensional disintegration control
EP2068757B1 (en) 2006-09-14 2011-05-11 Boston Scientific Limited Medical devices with drug-eluting coating
CA2663220A1 (en) 2006-09-15 2008-03-20 Boston Scientific Limited Medical devices and methods of making the same
EP2068782B1 (en) 2006-09-15 2011-07-27 Boston Scientific Limited Bioerodible endoprostheses
EP2081616B1 (en) 2006-09-15 2017-11-01 Boston Scientific Scimed, Inc. Bioerodible endoprostheses and methods of making the same
JP2010503491A (en) 2006-09-15 2010-02-04 ボストン サイエンティフィック リミテッド Bioerodible endoprosthesis with biologically stable inorganic layers
US8002821B2 (en) 2006-09-18 2011-08-23 Boston Scientific Scimed, Inc. Bioerodible metallic ENDOPROSTHESES
US7981150B2 (en) 2006-11-09 2011-07-19 Boston Scientific Scimed, Inc. Endoprosthesis with coatings
DE602007010669D1 (en) 2006-12-28 2010-12-30 Boston Scient Ltd HREN FOR THIS
US8070797B2 (en) 2007-03-01 2011-12-06 Boston Scientific Scimed, Inc. Medical device with a porous surface for delivery of a therapeutic agent
US8431149B2 (en) 2007-03-01 2013-04-30 Boston Scientific Scimed, Inc. Coated medical devices for abluminal drug delivery
US8067054B2 (en) 2007-04-05 2011-11-29 Boston Scientific Scimed, Inc. Stents with ceramic drug reservoir layer and methods of making and using the same
US7976915B2 (en) 2007-05-23 2011-07-12 Boston Scientific Scimed, Inc. Endoprosthesis with select ceramic morphology
WO2008154387A1 (en) * 2007-06-06 2008-12-18 Worldheart Corporation Wearable vad controller with reserve battery
US7942926B2 (en) 2007-07-11 2011-05-17 Boston Scientific Scimed, Inc. Endoprosthesis coating
US8002823B2 (en) 2007-07-11 2011-08-23 Boston Scientific Scimed, Inc. Endoprosthesis coating
JP2010533563A (en) 2007-07-19 2010-10-28 ボストン サイエンティフィック リミテッド Endoprosthesis with adsorption inhibiting surface
US8815273B2 (en) 2007-07-27 2014-08-26 Boston Scientific Scimed, Inc. Drug eluting medical devices having porous layers
US7931683B2 (en) 2007-07-27 2011-04-26 Boston Scientific Scimed, Inc. Articles having ceramic coated surfaces
US8221822B2 (en) 2007-07-31 2012-07-17 Boston Scientific Scimed, Inc. Medical device coating by laser cladding
JP2010535541A (en) 2007-08-03 2010-11-25 ボストン サイエンティフィック リミテッド Coating for medical devices with large surface area
US8052745B2 (en) 2007-09-13 2011-11-08 Boston Scientific Scimed, Inc. Endoprosthesis
US8626297B2 (en) * 2007-09-20 2014-01-07 Boston Scientific Neuromodulation Corporation Apparatus and methods for charging an implanted medical device power source
US7938855B2 (en) 2007-11-02 2011-05-10 Boston Scientific Scimed, Inc. Deformable underlayer for stent
US8029554B2 (en) 2007-11-02 2011-10-04 Boston Scientific Scimed, Inc. Stent with embedded material
US8216632B2 (en) 2007-11-02 2012-07-10 Boston Scientific Scimed, Inc. Endoprosthesis coating
US8187163B2 (en) 2007-12-10 2012-05-29 Ethicon Endo-Surgery, Inc. Methods for implanting a gastric restriction device
US8100870B2 (en) 2007-12-14 2012-01-24 Ethicon Endo-Surgery, Inc. Adjustable height gastric restriction devices and methods
US8377079B2 (en) 2007-12-27 2013-02-19 Ethicon Endo-Surgery, Inc. Constant force mechanisms for regulating restriction devices
US8142452B2 (en) 2007-12-27 2012-03-27 Ethicon Endo-Surgery, Inc. Controlling pressure in adjustable restriction devices
US8192350B2 (en) 2008-01-28 2012-06-05 Ethicon Endo-Surgery, Inc. Methods and devices for measuring impedance in a gastric restriction system
US8591395B2 (en) 2008-01-28 2013-11-26 Ethicon Endo-Surgery, Inc. Gastric restriction device data handling devices and methods
US8337389B2 (en) 2008-01-28 2012-12-25 Ethicon Endo-Surgery, Inc. Methods and devices for diagnosing performance of a gastric restriction system
US8221439B2 (en) 2008-02-07 2012-07-17 Ethicon Endo-Surgery, Inc. Powering implantable restriction systems using kinetic motion
US7844342B2 (en) 2008-02-07 2010-11-30 Ethicon Endo-Surgery, Inc. Powering implantable restriction systems using light
US8114345B2 (en) 2008-02-08 2012-02-14 Ethicon Endo-Surgery, Inc. System and method of sterilizing an implantable medical device
US8591532B2 (en) 2008-02-12 2013-11-26 Ethicon Endo-Sugery, Inc. Automatically adjusting band system
US8057492B2 (en) 2008-02-12 2011-11-15 Ethicon Endo-Surgery, Inc. Automatically adjusting band system with MEMS pump
US8034065B2 (en) 2008-02-26 2011-10-11 Ethicon Endo-Surgery, Inc. Controlling pressure in adjustable restriction devices
US8187162B2 (en) 2008-03-06 2012-05-29 Ethicon Endo-Surgery, Inc. Reorientation port
US8233995B2 (en) 2008-03-06 2012-07-31 Ethicon Endo-Surgery, Inc. System and method of aligning an implantable antenna
US8920491B2 (en) 2008-04-22 2014-12-30 Boston Scientific Scimed, Inc. Medical devices having a coating of inorganic material
US8932346B2 (en) 2008-04-24 2015-01-13 Boston Scientific Scimed, Inc. Medical devices having inorganic particle layers
US7998192B2 (en) 2008-05-09 2011-08-16 Boston Scientific Scimed, Inc. Endoprostheses
US8236046B2 (en) 2008-06-10 2012-08-07 Boston Scientific Scimed, Inc. Bioerodible endoprosthesis
US8449603B2 (en) 2008-06-18 2013-05-28 Boston Scientific Scimed, Inc. Endoprosthesis coating
US7985252B2 (en) 2008-07-30 2011-07-26 Boston Scientific Scimed, Inc. Bioerodible endoprosthesis
US8382824B2 (en) 2008-10-03 2013-02-26 Boston Scientific Scimed, Inc. Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides
ES2950025T3 (en) * 2008-10-10 2023-10-04 Implantica Patent Ltd Implant charger
US8751001B2 (en) * 2008-10-23 2014-06-10 Medtronic, Inc. Universal recharging of an implantable medical device
US8231980B2 (en) 2008-12-03 2012-07-31 Boston Scientific Scimed, Inc. Medical implants including iridium oxide
US20110304240A1 (en) 2008-12-21 2011-12-15 Sirius Implantable Systems Ltd. High efficiency piezoelectric micro-generator and energy storage system
WO2010101901A2 (en) 2009-03-02 2010-09-10 Boston Scientific Scimed, Inc. Self-buffering medical implants
US8071156B2 (en) 2009-03-04 2011-12-06 Boston Scientific Scimed, Inc. Endoprostheses
US8287937B2 (en) 2009-04-24 2012-10-16 Boston Scientific Scimed, Inc. Endoprosthese
US9555174B2 (en) 2010-02-17 2017-01-31 Flow Forward Medical, Inc. Blood pump systems and methods
KR101963799B1 (en) 2010-02-17 2019-03-29 플로우 포워드 메디컬, 인크. System and method to increase the overall diameter of veins
US9662431B2 (en) 2010-02-17 2017-05-30 Flow Forward Medical, Inc. Blood pump systems and methods
US20110218622A1 (en) * 2010-03-05 2011-09-08 Micardia Corporation Induction activation of adjustable annuloplasty rings and other implantable devices
US8668732B2 (en) 2010-03-23 2014-03-11 Boston Scientific Scimed, Inc. Surface treated bioerodible metal endoprostheses
US8766788B2 (en) 2010-12-20 2014-07-01 Abiomed, Inc. Transcutaneous energy transfer system with vibration inducing warning circuitry
DK2654878T3 (en) 2010-12-20 2019-07-22 Abiomed Inc TRANSCUTANT ENERGY TRANSFER SYSTEM WITH A MULTIPLE OF SECONDARY COILS
EP2654883B1 (en) 2010-12-20 2022-09-14 Abiomed, Inc. Method and apparatus for accurately tracking available charge in a transcutaneous energy transfer system
AU2012240239B2 (en) 2011-04-04 2017-01-05 Curonix Llc Implantable lead
EP3485819B1 (en) 2011-04-14 2022-09-07 Abiomed, Inc. Transcutaneous energy transfer coil with integrated radio frequency antenna
US8594804B2 (en) 2011-04-28 2013-11-26 Cyberonics, Inc. Implantable medical device charging
US9531195B2 (en) 2011-04-29 2016-12-27 Cyberonics, Inc. Inductively rechargeable implantable device with reduced eddy currents
RU2664156C2 (en) 2011-08-17 2018-08-15 Флоу Форвард Медикал, Инк., Сша System and method for increase of outer diameter of viens and arteries
BR112014003425B1 (en) 2011-08-17 2020-12-15 Flow Forward Medical, Inc BLOOD CENTRIFUGAL PUMP SYSTEM
US9343224B2 (en) * 2011-08-19 2016-05-17 Leviticus Cardio Ltd. Coplanar energy transfer
US9793579B2 (en) 2013-11-08 2017-10-17 Leviticus Cardio Ltd. Batteries for use in implantable medical devices
US20170216508A1 (en) * 2011-08-19 2017-08-03 Leviticus Cardio Ltd. Coplanar wireless energy transfer
US10543303B2 (en) 2013-11-08 2020-01-28 Leviticus Cardio Ltd. Batteries for use in implantable medical devices
US9642958B2 (en) 2011-08-19 2017-05-09 Leviticus Cardio Ltd. Coplanar wireless energy transfer
AU2012308197B2 (en) 2011-09-15 2016-10-27 Curonix Llc Relay module for implant
US9002468B2 (en) 2011-12-16 2015-04-07 Abiomed, Inc. Automatic power regulation for transcutaneous energy transfer charging system
KR101438887B1 (en) * 2012-05-25 2014-11-03 엘지이노텍 주식회사 Wireless power transmission device, power supplying device and power control method thereof
US10258730B2 (en) 2012-08-17 2019-04-16 Flow Forward Medical, Inc. Blood pump systems and methods
US9254393B2 (en) * 2012-12-26 2016-02-09 Micron Devices Llc Wearable antenna assembly
US9192705B2 (en) * 2013-03-25 2015-11-24 Thoratec Corporation Percutaneous cable with redundant conductors for implantable blood pump
US9225194B2 (en) 2013-04-24 2015-12-29 Cyberonics, Inc. Implantable medical device charging apparatus having both parallel and series resonators
US9855376B2 (en) 2014-07-25 2018-01-02 Minnetronix, Inc. Power scaling
US10149933B2 (en) 2014-07-25 2018-12-11 Minnetronix, Inc. Coil parameters and control
EP3200846B1 (en) 2014-10-01 2020-01-15 Heartware, Inc. Backup controller system with updating
US10342908B2 (en) 2015-01-14 2019-07-09 Minnetronix, Inc. Distributed transformer
DE102016100534A1 (en) 2015-01-16 2016-07-21 Vlad BLUVSHTEIN Data transmission in a transcutaneous energy transmission system
US10193395B2 (en) 2015-04-14 2019-01-29 Minnetronix, Inc. Repeater resonator
CA3021657A1 (en) 2016-04-29 2017-11-02 Flow Forward Medical, Inc. Conduit tips and systems and methods for use
US20220080089A1 (en) * 2020-09-15 2022-03-17 Medtronic, Inc. Coil shunting for voltage limiting of inductively transferred power

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3195540A (en) * 1963-03-29 1965-07-20 Louis C Waller Power supply for body implanted instruments
FR1379694A (en) * 1963-09-18 1964-11-27 Electronique Appliquee Advanced cardiac exciter
US3942535A (en) * 1973-09-27 1976-03-09 G. D. Searle & Co. Rechargeable tissue stimulating system
DE2720331A1 (en) * 1977-05-06 1978-11-09 Walter Holzer Heart pacemaker with rechargeable battery - has transformer type recharging system and frequency sensor monitoring battery condition
US4143661A (en) * 1977-12-12 1979-03-13 Andros Incorporated Power supply for body implant and method for operation
US4275739A (en) * 1979-01-26 1981-06-30 The Johns Hopkins University Charge control switch responsive to cell casing deflection
US4457673A (en) * 1980-11-28 1984-07-03 Novacor Medical Corporation Pump and actuator mechanism
US4384829A (en) * 1980-11-28 1983-05-24 Andros Incorporated Pump and actuator mechanism
US4548208A (en) * 1984-06-27 1985-10-22 Medtronic, Inc. Automatic adjusting induction coil treatment device

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9192704B2 (en) 2008-09-10 2015-11-24 Heartware, Inc. TET system for implanted medical device
US9504775B2 (en) 2008-09-10 2016-11-29 Heartware, Inc. TET system for implanted medical device
US9770544B2 (en) 2008-09-10 2017-09-26 Christopher & Weisberg, P.A. TET system for implanted medical device
US10137232B2 (en) 2008-09-10 2018-11-27 Heartware, Inc. TET system for implanted medical device
US10413651B2 (en) 2008-09-10 2019-09-17 Heartware, Inc. TET system for implanted medical device

Also Published As

Publication number Publication date
JPS63500288A (en) 1988-02-04
EP0231346A4 (en) 1989-07-11
WO1987000420A1 (en) 1987-01-29
DE3686648T2 (en) 1993-04-22
ATE80024T1 (en) 1992-09-15
EP0231346B1 (en) 1992-09-02
DE3686648D1 (en) 1992-10-08
EP0231346A1 (en) 1987-08-12
AU6191486A (en) 1987-02-10
DK145887A (en) 1987-03-20
US4665896A (en) 1987-05-19
JPH0761360B2 (en) 1995-07-05
DK145887D0 (en) 1987-03-20
BR8606805A (en) 1987-10-13

Similar Documents

Publication Publication Date Title
CA1287881C (en) Power supply for body implant
US10413651B2 (en) TET system for implanted medical device
CA2510074C (en) Medical implant having closed loop transcutaneous energy transfer (tet) power transfer regulation circuitry
US9125242B2 (en) Selectable resonant frequency transcutaneous energy transfer system
Si et al. A frequency control method for regulating wireless power to implantable devices
US3942535A (en) Rechargeable tissue stimulating system
EP1051790B1 (en) Automatic rate control for defibrillator capacitor charging
US5991665A (en) Self-cooling transcutaneous energy transfer system for battery powered implantable device
US6442434B1 (en) Methods and apparatus for providing a sufficiently stable power to a load in an energy transfer system
US5702431A (en) Enhanced transcutaneous recharging system for battery powered implantable medical device
US5735887A (en) Closed-loop, RF-coupled implanted medical device
US6745077B1 (en) Electronic impedance transformer for inductively-coupled load stabilization
US6240318B1 (en) Transcutaneous energy transmission system with full wave Class E rectifier

Legal Events

Date Code Title Description
MKLA Lapsed